Castle Biosciences, Inc. (CSTL) vs Personalis, Inc. (PSNL)
- Castle Biosciences, Inc. CSTL 31.96 −5.44%
- Personalis, Inc. PSNL 15.65 −1.76%
Castle Biosciences, Inc. and Personalis, Inc. are both Diagnostics & Research companies. Personalis, Inc. is the larger, with a market value of $1.7B against $1.0B — 1.7× the size. Castle Biosciences, Inc. grew revenue faster over the last twelve months: 3.18% against −13.3%. Castle Biosciences, Inc. has the higher net margin (−5.43% vs −153.8%) and the higher return on invested capital (−9.40% vs −317.5%). Across the 18 metrics below, Castle Biosciences, Inc. leads on 15 and Personalis, Inc. on 3.
Valuation
Profitability
| Metric | CSTL | PSNL | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 77.26% | 12.69% | 50.89% |
| Operating margin | (8.99%) | (164.07%) | (8.57%) |
| Net margin | (5.43%) | (153.84%) | (6.37%) |
| Free cash flow margin | (0.13%) | (144.76%) | 0.00% |
| Return on equity | (4.20%) | (50.32%) | (2.92%) |
| Return on assets | (3.51%) | (37.55%) | (6.71%) |
| Return on invested capital | (9.40%) | (317.48%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack